Reckitt Benckiser Group (RBGLY) Stock Analysis & Winston Score
Reckitt Benckiser is a British consumer goods company that makes health, hygiene, and nutrition products sold in homes around the world. Its well-known brands include Lysol disinfectants, Dettol soap, Mucinex cold medicine, Durex, and Enfamil infant formula. The company sells mostly to everyday consumers through grocery stores, pharmacies, and big-box retailers. Reckitt earns money by selling these branded products at a premium, relying on strong brand recognition to justify higher prices than generic alternatives — which explains its roughly 60% gross margin. It operates in over 60 countries, with major revenue coming from North America, Europe, and fast-growing emerging markets. The company's main competitive advantage is its portfolio of trusted, market-leading brands that consumers reach for out of habit. A key risk is ongoing legal liability tied to its Enfamil formula, where lawsuits allege links to a serious bowel disease in premature infants — a matter that could result in significant financial penalties.
Winston Score: 60/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Strong (23/30)
- Growth: Mixed (6/20)
- Cash Flow: Good (5/10)
- Stability: Good (6/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)

